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SUMMARY
Alternative splicing is prevalent in the mammalian brain. To interrogate the functional role of 
alternative splicing in neural development, we analyzed purified neural progenitor cells (NPCs) 
and neurons from developing cerebral cortices, revealing hundreds of differentially spliced exons 
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that preferentially alter key protein domains—especially in cytoskeletal proteins—and can harbor 
disease-causing mutations. We show that Ptbp1 and Rbfox proteins antagonistically govern the 
NPC-to-neuron transition by regulating neuron-specific exons. While Ptbp1 maintains apical 
progenitors partly through suppressing a poison exon of Flna in NPCs, Rbfox proteins promote 
neuronal differentiation by switching Ninein from a centrosomal splice form in NPCs to a non-
centrosomal isoform in neurons. We further uncover an intronic human mutation within a PTBP1 
binding site that disrupts normal skipping of the FLNA poison exon in NPCs and causes a brain-
specific malformation. Our study indicates that dynamic control of alternative splicing governs cell 
fate in cerebral cortical development.
Keywords
Filamin A; Ninein; Ptbp1; Rbfox; microcephaly; periventricular nodular heterotopia; mother 
centriole
INTRODUCTION
The neocortex is phylogenetically the newest part of the human brain with its projection 
neurons originating from waves of neurogenesis initiated by apical radial glial cells (aRG), 
followed by extensive radial neuronal migration (Gao et al., 2014; Greig et al., 2013; Huttner 
et al., 2013; Lui et al., 2011). RGCs maintain long basal processes attached to the pial 
membrane and undergo mitosis near their apical processes in the ventricular zone (VZ) or 
outer subventricular zone (oSVZ) to self renew or produce other types of progenitors 
including intermediate progenitors (IPs). IPs undergo limited numbers of divisions to 
produce neurons. In humans, the massive expansion of the cortex is accompanied by 
additional numbers of cell divisions, progenitor types and neuronal circuits by mechanisms 
that are poorly understood (Lui et al., 2011).
Alternative splicing (AS) regulates over 90% of multi-exon protein-coding genes in humans 
and exerts an evolutionarily conserved posttranscriptional control on genome-wide and 
tissue-specific gene expression (Barbosa-Morais et al., 2012; Merkin et al., 2012; Wang et 
al., 2008). Transcriptional profiling of mammalian forebrain has revealed dynamic AS 
changes between different brain regions (Johnson et al., 2009), cortical layers (Belgard et al., 
2011) or developmental stages (Dillman et al., 2013; Yan et al., 2015). Dysregulation of AS 
in human brain by RBFOX1 mutations or disturbed nSR100 levels has been associated with 
intellectual disability and autism spectrum disorders (ASD) (Bhalla et al., 2004; Irimia et al., 
2014; Sebat et al., 2007). nSR100, Ptbp1 and Rbfox proteins have also been reported to 
regulate AS of neuronal microexons (Irimia et al., 2014; Li et al., 2015). Recent studies have 
generated an unprecedented view of AS in cortical development (Darnell, 2013; Li et al., 
2007; Raj and Blencowe, 2015; Vuong et al., 2016), but the physiological impact of 
alternative splicing on cortical progenitor and neuronal fates remains unclear. On the one 
hand, systematic studies of cortical NPCs concentrated mostly on gene-level instead of 
exon-level expression or detected rather subtle AS changes (Ayoub et al., 2011). On the 
other hand, previous AS studies of the developing cerebral cortex centered on either RNA 
binding proteins (RBP) or individual alternative exons, rather than taking a global view of 
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cell type-specific regulation. Direct comparative investigations of alternative exon usage 
between cortical NPCs and neurons in a physiological context are not yet available.
We performed unbiased RNA sequencing (RNA-Seq) comparison of NPCs and neurons 
isolated directly from developing mouse and human cerebral cortices, and identified 
extensive and conserved AS switches during cortical NPC differentiation. We found that 
alternative splicing preferentially regulates genes encoding cytoskeleton proteins, modulates 
protein subcellular localization, and involves genes essential for brain development in mice 
and/or humans. Our results on dynamic switching of Ninein and Filamin A isoforms by 
Rbfox1/2/3 and Ptbp1 proteins reveal developmental roles of alternative splicing in 
regulating centriolar dynamics, NPC self-renewal and differentiation, uncovering 
widespread functions of alternative splicing in cerebral cortical development.
RESULTS
RNA Sequencing of Sorted NPCs and Neurons from Developing Mouse Cerebral Cortex 
Uncovers Extensive Alternative Exon Usage during Cortical NPC Differentiation
Using a Tbr2-EGFP transgene driving EGFP in dorsal cortex (Figure S1A) (Gong et al., 
2003), we found that E14.5 VZ NPCs (Sox2+; EGFP−) are well separated from IPs in the 
subventricular zone (SVZ, Tbr2+; EGFP+) and differentiating neurons in the intermediate 
zone (IZ) and cortical plate (CP, Sox2-; EGFP+, Figure 1A and Figure S1A). We isolated 
VZ NPCs (EGFP−) and non-VZ cells (EGFP+) from E14.5 Tbr2-EGFP cerebral cortex 
(Figure 1B), and confirmed their identities: (1) strand-specific RNA-Seq and quantitative 
PCR of sorted cells showed that NPC genes Sox2, Pax6, Nes and Hes1 were highly enriched 
in the (EGFP−) cells while Tbr1, Fezf2 and Neurod2 were enriched in the (EGFP+) cells 
(Figure 1C, Figure S1B); (2) the fourth exon of REST, expressed in differentiating neurons 
(Raj et al., 2011), was depleted from sorted (EGFP−) cells (Figure S1C); (3) 93.5% of sorted 
(EGFP−) cells were Sox2 positive (Figure S1D–E); (4) gene ontology analysis revealed that 
cell cycle, chromosomal and DNA metabolic genes were enriched in (EGFP−) cells, while 
neuron differentiation and projection genes were enriched in (EGFP+) cells (Figure S1F). 
These results indicate that we successfully isolated and analyzed VZ NPCs (EGFP−) and a 
mixture of IPs and neurons outside the VZ (hereafter referred to as non-VZ or neuron) from 
developing mouse cerebral cortex.
We compared alternative exon usage between E14.5 VZ NPCs and non-VZ cells using the 
mixture-of-isoforms (MISO) statistical model, which assigned a ‘percentage spliced in’ 
(PSI) value to each exon by estimating its abundance compared to adjacent exons (Katz et 
al., 2010). We found that 622 exons were differentially spliced between mouse NPCs and 
neurons (|ΔPSI|≥10% and Bayes factor ≥5, the same criteria used hereafter if not specified), 
with 345 showing higher inclusion in neurons and 277 higher in NPCs. We analyzed VZ and 
CP samples from two additional RNA-Seq datasets (Ayoub et al., 2011; Fietz et al., 2012), 
and found 742 AS changes shared by at least two of the three datasets (Figure 1D, Figure 
S1G). 272 cassette exons or skipped exons (SE) comprised the largest portion of AS events, 
with 198 (73%) SEs showing higher inclusion in neurons than in NPCs (Figure 1D), 255 
(94%) SEs shorter than 300 nt (Figure S1H), and 61 (22%) SEs causing frame shifts (Figure 
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1E). These results indicate that hundreds of alternative exon usages occur when VZ NPCs 
differentiate in mice.
Extensive Alternative Exon Usage during NPC Differentiation in the Developing Human 
Cerebral Cortex
The developing human cortex has an enormously expanded oSVZ housing the largest 
population of dividing progenitors, the most prominent being outer radial glial (oRG) cells 
that resemble aRG cells but lack apical processes. We compared laser microdissected oSVZ 
to VZ, inner SVZ (iSVZ) and CP (Fietz et al., 2012), as well as RNA-seq data from purified 
aRG and oRG cells (Johnson et al., 2015), and found that most splicing switches occur 
between neural progenitors in the VZ and neurons in the CP (2582 exons, Figure S1I–S1J), 
with 31% of human cassette exons (|ΔPSI|≥15%, Bayes factor ≥10) causing a translational 
frame shift (Figure S1K). When SE, A3SS, A5SS, MXE and RI (Figure 1D) were 
considered, 38% of mouse differential splicing events were also differentially spliced in 
human, including 113/272 (42%) mouse SEs (Figure 1F).
To compare AS between pure NPC and neuronal populations, we further analyzed RNA-Seq 
data of 224 single cells from three human fetal cortices (Camp et al., 2015). Using the 
unbiased pathway and gene set over dispersion analysis approach (PAGODA) (Fan et al., 
2016), we were able to identify distinct transcriptional subpopulations corresponding to 
RGs, IPs, immature neurons, and neurons (Fig 1G). We then pooled single RGs and single 
neurons in silico and extended our MISO analysis to these putatively pure RG and mature 
neuron populations, which gave rise to 298 significant cassette exon changes. Consistent 
with bulk samples, more SEs show higher inclusion in neurons (166) than in RGs (132). For 
26 SEs that were also identified in human bulk samples, ΔPSIs are significantly correlated 
between bulk and pooled single cell analyses (r^2 = 0.44, p-value = 1.7e-4, Fig 1H–1I). 
These results indicate that extensive alternative exon usages occur when VZ NPCs 
differentiate in mouse and human cerebral cortex and many of them may critically regulate 
gene function by shifting translational frames, though we focus here mainly on those shared 
by mouse and human to allow functional analysis of their mechanism.
Cytoskeleton Genes Are Preferentially Regulated by Alternative Splicing during 
Neurogenesis
Gene ontology analysis for differentially spliced exons revealed that cytoskeleton genes are 
overrepresented in mouse and human (Figure 2A, Figure S2A–S2B). KEGG pathway 
analyses of alternative exons also revealed enriched functions in regulating tight junctions 
and actin cytoskeleton (Figure S2C and data not shown). Differential mouse SEs between 
E14.5 NPCs and neurons were validated by RT-PCR, and many of these events were switch-
like (|ΔPSI| > 50%, Figures 2B–2F, and S2D–S2E, Table S1). Notably, alternatively spliced 
cytoskeleton genes encoded functionally interconnected protein networks (Figure 2G–2I) 
involved in NPC proliferation, neuronal migration and neuronal differentiation. Over a 
dozen genes alternatively spliced during the NPC-to-neuron transition--including Add1, 
Ank2, Flna, Kif2a, Macf1, Scrib, and Syne2--have previously been shown to be required for 
normal cerebral cortical development in mice (Table S2), and certain alternative exons 
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harbor mutations that associate with human brain disorders such as microcephaly and autism 
(Figure 2J–2M and below), suggesting cell type-specific mechanisms of human diseases.
Alternatively Spliced Exons Alter Protein Domains and Subcellular Localization
Exons that are differentially spliced between NPCs and neurons are remarkable in the extent 
to which they critically involve essential protein domains. Among 61 splicing changes in 49 
genes regulating cytoskeleton (Table S3), 20 (33%) of them caused insertion or deletion of 
one or more entire protein domains (Figure 3A–3B, Figure S3A–S3C). Multiple genes 
showed AS of membrane-targeting domains (Figure 3B), which typically regulate 
subcellular localization. Another 13 (21%) alternative exons--including a microexon--
inserted extra amino acids (extraAA) into well-defined protein domains (Figure 3A, Figure 
S3A and S3C). Thus, more than half (54%) of differentially spliced regions directly regulate 
protein domains.
Alternative Splicing Switches Ninein from Centrosome in NPCs to Non-centrosomal Loci in 
Neurons
We have shown a large Nin alternative exon 18 (> 2000 nt) that is almost exclusively 
included in mouse and human NPCs but skipped in neurons (Figure 2J–2K, ΔPSI = 
−83.5%). In contrast, we also identified a conserved 61 nt exon (exon 29) of Nin that is 
specifically included in neurons (CP) but skipped in NPCs (Figure 3C–3D, ΔPSI = 74.0%), 
introducing a frame shift and truncating the C-terminus of Nin (Figure 3E–3F). Nin 
associates with the mother centriole to anchor microtubules, with its C-terminal segment 
targeting efficiently to centrosomes (Delgehyr et al., 2005). Although Nin translocates from 
centrosome to noncentrosomal loci during brain progenitor cell differentiation, the 
underlying mechanism remains unknown (Baird et al., 2004; Ohama and Hayashi, 2009).
We examined the effects of exon 18 and exon 29 on Nin subcellular localization and found 
that the C-terminal centrosome-localization signal of Nin (Nin-NPC-CT) is lost with the 
inclusion of alternative exon 29, causing the neuronal Nin isoform (Nin-Neuron) to be 
diffusely localized in cytoplasm when highly expressed (Figure 3F–3G), associating with 
microtubules at non-centrosomal loci (Figure S3D–S3F). Targeted co-immunoprecipitation 
(co-IP) screen of centrosomal proteins allowed us to uncover that the Nin-NPC-CT 
specifically pulled down CEP250 (Figure 3H), and CEP250 knockdown disrupted the 
centrosomal localization of Nin (Figure 3I, Figure S3G). We further found that CEP170 
preferentially interacts with Nin-NPC through exon 18, but not the Nin-Neuron isoform 
(Figure 3H, Figure S3I). Given that CEP170 relies on Nin for its centrosomal localization 
(Graser et al., 2007), our data suggest that the Nin-CEP170 interaction is mediated by Nin 
exon18 and is dynamically regulated by alternative splicing. These results indicate a two-
fold alternative splicing mechanism: (1) inclusion of neuronal exon 29 dissociates Nin from 
CEP250 and centrosome, causing Nin to adopt a non-centrosomal localization in neurons; 
and (2) skipping of Nin exon 18 further dissociates CEP170 from Nin in neurons.
Endogenous Nin-Neuron is significantly elevated in postmitotic neurons during cortical 
neurogenesis (Figures S4A–S4B). Ectopic expression of Nin-Neuron, but not Nin-NPC, led 
to significant neural progenitor depletion from the VZ (Figure 4A–4B) and defective 
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neuronal migration into the CP (Figure S4C). We performed pair-cell assays, and found Nin-
Neuron expression causes significantly more NPCs to become neurons compared to control 
or the Nin-NPC isoform (Figure 4C–4D). Expression of Nin-Neuron disperses endogenous 
Nin and Dctn1--a key dynactin subunit mediating cytoplasmic dynein-cargo binding--from 
the centrosome (Figure 4E–4F), suggesting a dominant negative mechanism in regulating 
cell fate. We thus created a NIN knockout cell line (Chr14:51,259,547delT (hg19), 
p.Arg107Thrfs*16, Figure S4D) and found that loss of centrosomal NIN disrupted normal 
mitotic cleavage planes (Figure 4G–4H). These results indicate that endogenous switching 
of Nin-NPC to the Nin-Neuron isoform is sufficient to convert cortical NPCs to neurons, 
suggesting that neurogenesis is normally controlled at least in part by alternative splicing of 
Nin.
Aberrant Splicing of A Cryptic Poison Exon Causes A Unique Brain Malformation
Splicing analysis identified a highly conserved but not previously annotated 57 nt exon in 
Flna that is skipped in E14.5 NPCs (VZ) and most adult tissues, but included in mRNAs 
from E14.5 neurons (CP) as well as adult cortex and cerebellum (Figure 5A). Surprisingly, 
an in-frame stop codon was embedded in this neuron-specific Flna exon (Figure 5B and 
Figure S5A), inclusion of which causes early truncation of Flna protein (482 of 2647 amino 
acids, Figure 5C), and/or nonsense-mediated mRNA decay (NMD, Figure 5D). We thus 
name the Flna SE “exonN” (N stands for Null in Neuron), and found that the human 
homologous exonN is skipped in VZ while included in CP (Figure 5E). The skipping of 
exonN in cortical NPCs creates a full-length protein, whereas splicing into this exon in 
neurons would give a truncated protein or unstable mRNA. Remarkably, genomic sequences 
of exonN including the embedded stop codon are conserved across multiple placental 
mammalian species, though it is not observed outside mammals (Figure 5F).
The presence of poison exons encoding translational stop codons reported here and by other 
groups (Yan et al., 2015) suggests a potential mechanism of human disease that to our 
knowledge has not been previously described: mutations that disrupt normal suppression of 
a poison exon would inactivate protein expression in a cell that normally skips the exon. We 
tested this model by studying FLNA, since heterozygous null mutations in females typically 
cause periventricular heterotopia (PVNH), where neurons form nodules along the VZ, 
reflecting failure of normal migration (Fox et al., 1998). We hypothesized that, since 
abnormal inclusion of exonN will create a FLNA null allele (Figure 5B–5F), mutations that 
promote exonN inclusion in NPCs may lead to PVNH.
Sequencing FLNA exonN and its flanking introns in 221 individuals with genetically 
unexplained PVNH revealed a rare variant FLNA-as (ChrX: 153,594,210 C>T, c.1429+182 
G>A) in a large family in which multiple individuals show PVNH that is notably milder than 
that caused by FLNA null alleles (Figure 5G–5I). Unlike typical females with heterozygous 
FLNA null mutations, who have abnormally located neurons lining the entire lateral 
ventricles bilaterally, the PVNH in FLNA-as patients is striking, but limited to smaller 
segments of the VZ, often asymmetrically (Figure 5G). The FLNA-as mutation lies in the 
upstream intron of exonN (Figure 5J), and leads to abnormal exonN inclusion in patient 
blood cells, where exonN is normally skipped (Figure 5K). Furthermore, FLNA null 
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mutations are usually male lethal, yet affected males in this family do not show early 
lethality. Males and females with null FLNA mutations also show variably penetrant 
congenital heart disease and severe vascular catastrophes (Fox et al., 1998), but the FLNA-as 
pedigree shows no clear evidence of cardiovascular disease, suggesting that the FLNA-as 
mutation may cause a central nervous system (CNS)-specific and cell type-specific 
phenotype.
We expressed wild-type (WT) and mutated FLNA mini-genes in Neuro2a cells (Figure 5J 
and 5L–5M) and in E14.5 mouse cortical NPCs (Figure 5N) and found that the WT mini-
gene produced transcripts that skipped exonN (PSI<5%), while the mini-gene with the 
FLNA-as mutation produced 40%–50% of FLNA transcripts that abnormally included 
exonN or the last 8-nt of exonN that creates a frame shift (Figure 5L, 5N, Figure S5B). 
FLNA-as mutation led to a truncated FLNA mini-protein and reduced levels of mini-proteins 
(Figure 5M). These results confirm that the c.1429+182 G>A mutation promoted abnormal 
exonN inclusion in NPCs, creating a cell type- and tissue-specific FLNA partial loss-of-
function and an atypical PVNH syndrome.
Ptbp1 and Rbfox1/2/3 Antagonistically Regulate Neuronal Exon Inclusion in the Developing 
Cerebral Cortex
We used DREME (Bailey, 2011) to identify discriminative cis-regulatory sequence motifs 
enriched in the flanking introns of cassette exons that are preferentially included in neurons. 
The only two significant motifs identified correspond to binding motifs of Ptbp1/2 (CU(C/
U)UCUU, found within 200 nts in the upstream intron, p-value=3.6e-9), and Rbfox1/2/3 
(GCAU(G/A), within 200 nts in the downstream intron, p-value =1.3e-8, Figure 6A). 
Notably, 61% of alternatively spliced neuronal exons had Ptbp1/2 and/or Rbfox1/2/3 
regulatory motifs (Figure S6A). Analyses of Rbfox HITS-CLIP and Ptbp1 iCLIP datasets 
from neuronal samples (Linares et al., 2015; Weyn-Vanhentenryck et al., 2014) further 
support that many cortically regulated exons exhibit direct binding by these proteins (Figure 
S6B, Table S4 and below).
It has been shown that Ptbp1 binding upstream suppresses exon inclusion (Keppetipola et 
al., 2012), whereas Rbfox binding downstream enhances exon inclusion (Kuroyanagi, 2009; 
Wang et al., 2008). We found that Ptbp1 mRNAs and proteins were highly expressed in 
NPCs (VZ), with Rbfox1/2/3 specifically expressed in neurons (CP, Figures 6B and S6C), 
consistent with the positional enrichment around neuron-specific exons. Knock down of 
Ptbp1, but not Ptbp2, de-repressed inclusion of predicted neuronal exons including Flna 
exonN (Figure 6C–6D, Figure S6D–S6E), and resulted in decreased Flna protein expression 
(Figure 6E). Moreover, the protein levels of Ptbp1 and Flna were high in E12.5 mouse 
cortex and dropped over similar time-courses during cortical development (Figure S6F). 
Analysis of Ptbp1 iCLIP-Seq datasets (Linares et al., 2015; Masuda et al., 2012) revealed 
that Ptbp1 bound to the alternatively spliced Flna exonN in both NPCs and C2C12 cells 
(Figure 6F). The mouse homologous nucleotide (chrX:71,486,253) of the PVNH-associated 
FLNA c.1429+182 G>A mutation lies within a Ptbp1 iCLIP cluster (Figure 6F), suggesting 
that the human mutation disrupts splicing regulation via PTBP1.
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Expression of Rbfox1/2/3 proteins significantly promoted inclusion of predicted neuronal 
exons (Figure 6G, Figure S6G–S6H), especially Nin exon 29 (Figure 6H), which led to 
decreased endogenous Ninein at the centrosome (Figure 6I). Re-analysis of Rbfox-1/2/3 
HITS-CLIP datasets from P15 mouse brains (Weyn-Vanhentenryck et al., 2014) revealed 
that Rbfox1 and Rbfox3 bound to a conserved GCAUG motif, and Rbfox2 CLIP tags 
mapped to a different but adjacent GCAUG motif (Figure 6J and S6I). These results indicate 
that Rbfox proteins bind to the downstream intron of Nin exon 29 and promote exon 
inclusion. In summary, Ptbp1 in NPCs suppresses splicing of a family of neuronal exons 
including Flna exonN, while Rbfox1/2/3 in neurons promotes inclusion of over 120 neuronal 
exons including Nin exon 29. Thus, Ptbp1 and Rbfox1/2/3 proteins antagonistically regulate 
neuronal exon inclusion during the NPC-to-neuron transition in vivo.
Rbfox Proteins and Ptbp1 Antagonistically Regulate Neurogenesis in Cerebral Cortical 
Development
Conditional knockout (cKO) of Ptbp1 in mouse cerebral cortex causes NPCs to detach from 
the VZ and differentiate prematurely, leading to lethal hydrocephalus, but the pathogenic 
mechanism and direct downstream targets remain unknown (Shibasaki et al., 2013). We 
found that Ptbp1 cKO strikingly phenocopied human PVNH caused by FLNA mutations 
(Figure 7A), and that protein levels of both Flna and its paralog Flnb were significantly 
decreased in Ptbp1 knockout cells (Figure 7B). Flna exonN was skipped in controls but 
abnormally included in Ptbp1 cKO (Figure 7C). We identified an unannotated 98 nt exon of 
Flnb in the homologous location to Flna exonN, and this Flnb exon was also aberrantly 
included in Ptbp1 cKO (Figure 7C), and is predicted to cause a translational reading frame 
shift. These results indicate that Ptbp1 represses inclusion of Flna and Flnb poison exons in 
NPCs, and Ptbp1 loss-of-function leads to decreased Flna/Flnb levels and PVNH.
FLNA mutations cause PVNH in humans (Fox et al., 1998) and Flna knockout mice show 
microcephaly, defective adherens junctions and reduced cortical progenitors (Feng et al., 
2006; Lian et al., 2012). To test whether Flna functions downstream of Ptbp1, we knocked 
down Ptbp1 in E13.5 mouse cortical progenitors and found this led to fewer NPCs in the VZ 
due to abnormal cell cycle exit (Figures 7D–7E, and S7A–S7C). Introduction of exogenous 
FLNA by in utero electroporation (IUE) partially rescued the premature NPC depletion 
phenotype (Figure 7D–7E), supporting the model that Ptbp1 functions upstream of Flna in 
cortical neurogenesis.
Ptbp1 represses neuronal fate in tissue culture cells (Xue et al., 2013), and we found that 
Ptbp1 expression in the developing mouse cortex was highly correlated with Sox2 (Figure 
S7D). Sox2 is a master transcriptional regulator of NPC identity and indeed, Sox2 bound to 
the highly active Ptbp1 promoter region in NPCs (main peak = 398nt, fold enrichment= 7.6, 
p-value =1.0e-16, Figure S7E), suggesting that Ptbp1 is an important target of Sox2 in 
suppressing neuronal differentiation.
Single knockout of Rbfox1 or Rbfox2 causes minimal structural malformation in mouse 
cerebral cortex possibly due to gene redundancy (Gehman et al., 2012; Gehman et al., 2011). 
However, of particular interest is the consequence of Rbfox1/2/3 gain-of-function in NPCs, 
because Rbfox proteins promote neuronal exon inclusion and have long been used as pan-
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neuronal markers. Ectopic expression of Rbfox proteins in NPCs not only significantly 
decreased the number of VZ NPCs but also dramatically reduced the number of neurons in 
the CP (Figure 7F–7G). Furthermore, combining Rbfox3 expression with Ptbp1 knock down 
led to a more severe depletion of VZ NPCs (Figure 7F–7G). These data indicate that 
Rbfox1/2/3 and Ptbp1 antagonistically regulate neurogenesis in the developing cerebral 
cortex (Figure 7H).
DISCUSSION
Here we show that widespread alternative exon usage during the NPC-to-neuron transition in 
vivo is critical for mouse and human brain development. Neuronal fate and neuronal exon 
inclusion are antagonistically regulated by Ptbp1 and Rbfox1/2/3, which are expressed in 
NPCs and neurons, respectively. While Rbfox1/2/3-induced splicing causes Nin to be 
translocated from the centrosome in NPCs to non-centrosomal loci in neurons, the 
expression of Ptbp1 is required for apical progenitor lamination through maintaining Flna 
and Flnb expression in NPCs.
Perhaps most remarkable in our study is the fact that two opposite and extreme alternative 
splicing events in a single target gene, Ninein, appear sufficient to differentiate NPCs to 
neurons by removing CEP170- and CEP250-binding domains/exons. This alternative 
splicing mechanism of Nin may also explain previously described microtubule re-
organization phenomena during epidermal differentiation (Lechler and Fuchs, 2007) and 
could potentially regulate epidermal differentiation itself. While our unbiased motif analysis 
revealed the robust enrichment of Ptbp1/2- and Rbfox1/2/3-binding sequences flanking 
neuronal exons during the NPC-to-neuron transition, other RBPs may synergistically 
regulate neuronal exon usage in a context-dependent manner. ELAVL, NOVA, nSR100 and 
STAR proteins have been reported to regulate specific AS events during cerebral cortical 
development (Calarco et al., 2009; Darnell, 2013; Iijima et al., 2011), and some of these 
factors are also differentially expressed between cortical NPCs and neurons.
To our surprise, the brain-specific Ptbp1 knockout is a mouse model for PVNH (Figure 7A 
and (Shibasaki et al., 2013)). While FLNA mutations were linked to human PVNH two 
decades ago, Flna knockout mice only recapitulate the cardiovascular defects in human 
patients but do not exhibit PVNH (Feng et al., 2006), likely due to redundant functions of 
Flnb. Ptbp1 loss disrupts both Flna and Flnb, causing radial glia to detach from apical 
surface, and forming PVNH. These results demonstrate the essential roles of the Ptbp1-
Filamin axis in maintaining NPCs and neuroepithelial structure.
As expected from the cell type-specific splicing of FLNA, the intronic FLNA-as mutation 
de-represses exonN inclusion and leads to a unique presentation of PVNH with the absence 
of non-CNS manifestations, suggesting the preferential use of this alternative-splicing 
mechanism in brain. The homologous nucleotide of the FLNA c.1429+182 G>A mutation 
lies within a Ptbp1 iCLIP cluster (Figure 6F), suggesting that the human mutation disrupts 
splicing regulation via PTBP1. In agreement with this, a computational model of Ptbp1 
binding based on iCLIP clusters reported that interspersed G residues are well tolerated, but 
that A residues always impair Ptbp1 binding (Han et al., 2014).
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This study reveals that cell type-specific alternative splicing—frequently associated with 
alternative stop codons and NMD—is widespread in the central nervous system at early 
developmental stages, and provides functional insights into developmental roles for some of 
these alternative exons and their upstream splicing regulators. The active usage of many 
other cell type-specific poison exons demonstrates not only the demand for larger efforts in 
genetic testing of their flanking non-coding elements, but also the potential of uncovering 
more master splicing regulators that may play important roles in neurological disorders.
METHODS AND RESOURCES
CONTACT FOR REAGENT AND RESOURCE SHARING
Please contact C.A.W. (christopher.walsh@childrens.harvard.edu) for reagents and resources 
generated in this study.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mouse Maintenance
Mouse protocols were reviewed and approved by Institutional Animal Care and Use 
Committee (IACUC) at Boston Children’s Hospital (BCH) and all colonies were maintained 
following animal research guidelines at BCH. The Tbr2-EGFP transgenic mouse line, for 
which an EGFP-PolyA cassette was inserted in front of the translational start codon in a 
FVB/NTac mouse stain, was obtained from GENSAT (Gong et al., 2003) and crossed to the 
FVB inbreed strain for at least two generations. Heterozygous transgenic mice did not 
display any obvious developmental defects. Dorsal cerebral cortices were dissected from 
embryonic day 14.5 (E14.5) heterozygous Tbr2-EGFP transgenic embryos and pooled for 
splicing analyses without distinguishing genders.
Human Subjects
All human protocols were reviewed and approved by the institutional review board of BCH. 
Informed consent was obtained from all subjects involved in this study or from parents of 
those who were younger than 18 years old. PVNH cases screened in this study were 
recruited from diverse ethic groups and a Caucasian pedigree carrying the FLNA-as 
mutation is described. Mutations were detected with DNA extracted from blood samples. 
Splicing analyses of affected individuals were performed with RNA samples extracted from 
immortalized lymphoblasts.
Isolation of Primary Cells from the Developing Mouse Cerebral Cortex
Dissected brain tissues are dissociated with the Papain Dissociation System (Worthington). 
Single cell suspension (Neural Basal medium supplemented with 2% B27, 1% N2, 1% 
Penicillin Streptomycin (PenStrep), 10ng/ml EGF, 10ng/ml FGF2, 0.5% FBS and 0.25% 
HEPES) was cooled on ice and immediately sorted on the FACSAria II (BD). For 
immunostaining, sorted cells were plated in Lab-Tek chamber slides (Thermo) and cultured 
for 4 hours before fixation.
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Tissue Culture Cells
Cell lines including Neuro2a (a neuroblastoma cell line with a NPC-like state), Hela and 
Ptbp1 cKO MEF cells were used for transfection (Lipofectamine 2000, Life Tech) or 
lentiviral transduction. Lentiviral vectors were packaged and infected following the The 
RNAi Consortium (TRC) protocols. Briefly, the envelop plasmid (pMD2.G, Addgene, 
12259), packaging plasmid (psPAX2, Addgene, 12260), and pLKO.1 based vectors were 
cotransfected into HEK 293T/17 (ATCC, CRL-11268), and viral particles were harvested 42 
hours post-trasfection. Ptbp1 cKO MEF cells were transduced with lentiviral particles 
carrying control plasmid or CMV-Cre for protein and RNA analyses. To generate NINEIN 
knockout cell line, pX459 (Addgene 48139) carrying guide sequences were transfected into 
Hela cells and puromycin (5µg/ml) selected colonies were screened for mutant alleles.
METHOD DETAILS
RNA Sequencing analysis
Total RNA was extracted using RNeazy Mini Kit (Qiagen) and treated with Turbo DNase 
(Ambion). RINs measured by Bioanalyzer (Agilent) for all samples were above 9.0. 500–
2000ng total RNA was treated with Ribo-Zero Gold (Epicentre), and mRNA was enriched 
using Oligo(dT)25 Dynabeads (Life Tech). RNA-Seq libraries (2 replicates each for VZ and 
non-VZ cells, n or number of embryos= 7 and 11 for VZ, n=7 and 8 for non-VZ replicates) 
were prepared using ligation-based directional RNA-Seq kit (Bioo Scientific), and 
sequenced on Illumina HiSeq2000. 36 to 42 million single reads (50bp) were obtained for 
each replicate, trimmed, aligned (mm9, Tophat-2.0.7, allowing 2 mismatches) and analyzed 
using the Tuxedo protocol (Kim et al., 2013; Trapnell et al., 2012). Gene expression levels 
are presented as FPKM (Fragments Per Kilobase of exon per Million reads). Gene ontology 
analyses were performed using the DAVID online tools (Huang da et al., 2009).
Alternative Splicing Analysis
Aligned bam files (mm9) were analyzed using MISO (version 0.4.6). PSI values of each 
non-VZ replicate were compared to each VZ replicate, only alternative splicing events that 
were consistent across all comparisons were considered for downstream analysis. Additional 
RNA-Seq datasets of laser microdissected cortical tissues (Ayoub et al., 2011; Fietz et al., 
2012) were analyzed using the same pipeline. Sashimi plots of RNA-Seq reads were 
generated in Integrative Genomics Viewer (IGV) (Robinson et al., 2011; Thorvaldsdottir et 
al., 2013). To study alternative splicing changes during human brain development, published 
RNA-Seq datasets (Fietz et al., 2012) on laser microdissected fetal human cortical tissues 
across GW13–16 were aligned to human genome (hg19) and analyzed using the MISO 
pipeline. Alternatively spliced human exons (|ΔPSI|≥10%, and Bayes factor ≥5) were lifted 
over to the mouse genome (mm9) and compared to splicing events identified in E14.5 mouse 
cortex (Figure 1D). RNA-Seq datasets from the ENCODE project were analyzed for tissue 
distribution of alternative exons.
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Motif Analysis
We performed DREME (Bailey, 2011) motif discovery in each of the four regions around 
differentially spliced cassette exons in mouse: the first 200 nts (i.e. 5’ end) of the upstream 
intron, the last 200 nts (i.e. 3’ end) of the upstream intron, the first 200 nts of the 
downstream intron, and the last 200 nts of the downstream intron. For each region, we used 
exons with higher PSI in neurons as foreground, and exons with higher PSI in NPCs as 
background, and verse versa. DREME (version 4.9.0) were then run with the option ‘-norc –
e 0.05’ to identify significant motifs in each region.
Chip-Seq Analysis
Chip-Seq reads for Sox2 (Lodato et al., 2013) and H3K27ac (Creyghton et al., 2010) on 
NPCs cultured in vitro were trimmed, and aligned to the mouse genome (mm9) with Bowtie 
2.2.4 (Langmead and Salzberg, 2012) allowing zero or one mismatch. Mapped reads were 
visualized in IGV. Peaks were called using MACS 2.1.0 (Zhang et al., 2008) and statistical 
results were presented.
Molecular Cloning
pCAGIG (Addgene, 11159) vector and its derivatives were used for ectopic expression of 
genes in the neuronal system. First, the multiple cloning sites (MCS) between EcoR I and 
Not I was replaced with EcoR I-ATG(start codon)-HA(1x)-Flag(1x)-Asc I-Not I. Next, the 
EGFP expression cassette between Msc I and Fse I was replaced with either an mCherry or 
Puromycin resistance cassette. Coding or genomic sequences of specific genes (e.g., 
genomic sequences of WT human FLNA between exon 8 and exon 12 and the same 
sequence carrying the c.1429+182 G>A mutation) were PCR amplified and inserted 
between Asc I and Not I sites. To knockdown Ptbp1 and Ptbp2 in Neuro2a cells, oligos were 
annealed and cloned into pLKO.1 TRC cloning vector (Addgene, 10878) between EcoR I 
and Age I sites. To knockdown Ptbp1 expression in mouse brains, effective hairpins tested in 
Neuro2a cells (#3) and a control hairpin were end-modified and cloned into the pLL3.7 
vector (Addgene, 11795) between Hpa I and Xho I sites. For reverse transcription and 
polymerase chain reaction (RT-PCR), cDNAs from independent samples were amplified 
with Phusion (NEB) for 26–30 cycles and analyzed on agarose gels or Novex TBE gels (Life 
Tech). qRT-PCR (quantitative RT-PCR) were carried out using SYBR Green (ABI). Oligo 
sequences are listed in Table S5, and plasmids are listed in Table S6.
Protein Analysis
Protein domains were analyzed using Pfam (Finn et al., 2014). 3-D protein structures were 
predicted on the SWISS-MODEL and Phyre2 servers (Kelley and Sternberg, 2009). Protein 
lysates were resolved on SDS-PAGE gels and Western Blots were carried out using the Licor 
Odyssey system. For immunofluorescence staining (IF), embryonic mouse brains were 
dissected out, fixed in 4% paraformaldehyde, and coronal sections were obtained using a 
Vibratome or Cryostat (Leica Biosystems). Tissue sections or fixed tissue culture cells were 
rinsed twice in 1x PBS with 0.2% Triton X-100 (PBST) and incubated at room temperature 
in a blocking solution (PBST and 4% normal donkey serum), followed by incubation with 
primary antibodies at 4°C overnight. Samples were then washed 3 times with PBST and 
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incubated with fluorescence conjugated secondary Alexa antibodies (Life Technologies) at 
room temperature for 2 hours. Slides were mounted with Fluoromount G (Southern Biotech) 
and imaged on Imager M2 (Carl Zeiss). Primary antibodies are listed in Key Resource Table.
In utero Electroporation (IUE)
IUE was performed following standard protocols (Saito, 2006). In brief, a timed pregnant 
CD-1 mouse (E13.5) was anesthetized with isoflurane, laid on a 37°C warm plate, the 
uterine horns exposed and bathed in warm 1x HBSS (1% Pen/Strep), and ~1 µl of plasmid 
DNA (1–2µg/ µl) mixed with Fast Green was microinjected into the lateral ventricles of 
embryos using a glass micropipette (Drummond Scientific). Five 50 ms pulses of 30–50 mV 
at 950-ms intervals were delivered across the uterus with a pair of electrode paddles placed 
on each side of the embryo’s head using a square-pulse electroporator (BTX, ECM 830). 
Following electroporation, the uterus was repositioned back into the abdominal cavity and 
the wound was surgically sutured. The whole process was performed in a sterile 
environment. After surgery, the animals were closely monitored until they recovered and 
resumed normal activity. Pair-cell assays were performed following published protocols 
(Shen et al., 2002). Briefly, in utero electroporated NPCs expressing ectopic Nin isoforms 
were dissociated, FACS sorted, plated at clonal density and their progeny pair classified as 
progenitors (Sox2+; Tuj1−), neurons (Sox2−; Tuj1+) or a mixture.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses for differential gene expression and splicing changes (Figures 1, 2 and 6) 
were performed in R and MISO. Levels of significance were calculated with Student’s t-test 
for Figure 6I, and with Hypergeometric Test for Figure S6B. Isoform abundance on DNA 
gels was measured in Photoshop and normalized with DNA length. For statistical analyses 
of cell fates (Figure 4 and Figure 7), five to thirteen positive embryos were analyzed for each 
condition (specific numbers of analyzed embryos are indicated in each figure), and three to 
four sections were examined for each embryo. Percentages presented Figure 4 and Figure 7 
were calculated by dividing the number of EGFP+ cells in each zone (eg, VZ, IZ/SVZ and 
CP) by the total number of EGFP+ cells of all zones on the same images. Percentages of 
cells in the VZ were compared using one-way ANOVA in GraphPad Prism, and means +/− 
(standard deviation, SD) are presented. In all figures: *, p-value < 0.05; **, p-value < 0.01; 
***, p-value < 0.001.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Extensive and Conserved Alternative Exon Usages During Cerebral Cortical NPC 
Differentiation
A) Immunostaining of E14.5 Tbr2-EGFP mouse dorsal cerebral cortex with anti-EGFP 
(green) and anti-Sox2 (magenta).
B) Fluorescence-activated cell sorting (FACS) of green and non-green cells from E14.5 
Tbr2-EGFP mouse dorsal cerebral cortex.
C) Heatmap of RNA-Seq results showing differential gene expression between sorted VZ 
and non-VZ cells.
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D) Number of alternative exons between neural progenitor cells (NPC) and differentiating 
neurons.
E) Histogram showing the size of mouse SEs (x axis) and the percentages of SEs that cause 
an in-frame insertion or a frame shift (y axis).
F) Conserved SEs in mouse and human cortical neurogenesis.
G) PAGODA analysis distinguishes 224 single fetal cortical cells (Camp et al., 2015) into 4 
clusters (green, blue, red, yellow). Shown at the bottom are gene expression patterns for 
selected marker genes.
H) ΔPSI scores between pooled single cells and bulk samples show significant correlation.
I) Sashimi plots from bulk and single cell analyses showing the last three exons of CERS5.
See also Figure S1.
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Figure 2. Alternative Splicing Preferentially Regulates Genes Encoding Cytoskeleton Proteins
A) Ontology analysis of genes that are alternatively spliced between E14.5 mouse NPCs and 
differentiating neurons, showing the top 10 ranked terms and count of genes (in parenthesis).
B) RT-PCR analyses validate 57 AS events identified by MISO. ΔPSI = PSI (Neuron) – PSI 
(NPC).
C) to F) RT-PCR validation of alternatively spliced SEs related to microtubule C), actin (D), 
Add1-Ank2-Epb4.1 complex (E) and synapse (F). “E14.5 cc” represents unsorted E14.5 
mouse cerebral cortex.
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G) to I) Cartoon illustrations of alternatively spliced genes involved in NPC proliferation 
(G), radial neuronal migration (H) and neuronal differentiation (I).
J) RNA-Seq reads of human NIN gene in GW13-16 VZ and CP (left), showing that the 2139 
bp alternative exon is included in VZ (shaded in light blue). Red bars indicate mutations 
associated with microcephaly, one of which lies in the AS exon (Dauber et al., 2012). The 
black arrows here and in all following genome browser figures indicate the direction of gene 
transcription.
K) qRT-PCR results show that the 2121 bp mouse homologous Nin exon is included in VZ 
but skipped in non-VZ cells. Data are represented as mean +/− SEM.
L) RNA-Seq reads of human ANK2 gene showing the 6255bp alternative exon (shaded) is 
included in CP. Red bars indicate mutations associated with autism spectrum disorder, two 
of which lie in the AS exon (Iossifov et al., 2014).
M) qRT-PCR analysis showing that the mouse homologous Ank2 exon of L) is included in 
non-VZ and skipped in VZ. Data are represented as mean +/− SEM.
See also Figure S2 and Tables S1–S2.
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Figure 3. Cell Type-specific Alternative Splicing Translocates Ninein from Centrosome in NPCs 
to Non-centrosomal Loci in Neurons
A) Impact of 61 cytoskeleton-related and conserved AS events on modular protein domains. 
AA, amino acids. CT, C-terminus.
B) Alternative splicing alters protein domains that regulate subcellular localization. Gene 
names are followed by ΔPSI values. Differential protein domains are shaded red (neuron) or 
cyan (NPC).
C) RNA-Seq reads in E14.5 mouse VZ and CP, and GW13-16 human VZ and CP showing 
that the alternative Nin (NIN) exon 29 is specifically included in neurons (CP).
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D) RT-PCR validates the specific inclusion of Nin exon 29 in differentiating neurons.
E) Alignment of Nin exon 30, showing that insertion of exon 29 introduces a conserved 
premature stop codon.
F) –G) Cartoon illustration of EGFP-Nin fusion constructs and their subcellular localization 
in transfected cells.
H) Left: co-IP of transfected Ninein isoforms showing that Nin-NPC, but not the Nin-
Neuron isoform, pulls down CEP170 and CEP250. Right: co-IP showing that endogenous 
Ninein interact with CEP170 and CEP250 in Hela cells.
I) siRNA knockdown of CEP250 disrupts the centrosomal localization of Ninein.
See also Figure S3 and Tables S3.
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Figure 4. Ninein Neuronal Isoform Promotes NPC Differentiation
A–B) Expressing Nin-Neuron, but not the Nin-NPC isoform, in E13.5 mouse brains leads to 
fewer NPCs in the VZ at E15.5. Numbers in parentheses indicate the number of embryos (n) 
analyzed. Data are represented as mean +/− SD.
C–D) Pair-cell analyses showing that expression of Nin-Neuron promotes neuron 
production. P, progenitor; N, neuron. Data are represented as mean +/− SD.
E) Expression of Nin-Neuron isoform decreases the level of endogenous NIN at the 
centrosome.
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F) Expression of Nin-Neuron disperses Dctn1 away from centrosome.
G) NIN signal is diminished in NIN knockout cells.
H) NIN loss-of-function leads to defective mitotic spindles. Data are represented as mean +/
− SD.
See also Figure S4.
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Figure 5. Cell Type-specific Alternative Splicing of Filamin A in Cerebral Cortical Development 
and Human PVNH
A) RNA-Seq reads around Flna exonN showing its higher inclusion in adult cerebral cortex, 
cerebellum and E14.5 CP, in comparison to E14.5 VZ and other non-neural adult tissues.
B) Flna exonN has an in-frame stop codon.
C) ExonN inclusion is predicted to truncate Flna protein.
D) Blocking of NMD by cycloheximide (CHX) in primary hippocampal neurons cultured in 
vitro for 1 day increases inclusion of exonN. Data are represented as mean +/− SEM.
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E) RNA-Seq reads showing the inclusion of exonN and retention of its upstream intron in 
fetal human CP.
F) Filamin A exonN is conserved across representative placental mammals.
G) T1 brain MRI shows PVNH (white arrows) in affected individuals PH-01 (male) and 
PH-04 (female), compared to a healthy control and an unrelated individual with a FLNA null 
mutation.
H) Pedigree showing inheritance of PVNH and the rare c.1429 +182 G>A mutation.
I) Sanger sequencing traces showing the rare FLNA variant c.1429+182 G>A.
J) A cartoon illustrating the FLNA mini-gene construct and primers used for RT-PCR. N-
terminal HA and Flag tags were fused in-frame with exon 8.
K) RT-PCR using primer F and R1 (inside exonN) detecting the abnormal exonN inclusion 
in blood samples of affected individuals.
L) RT-PCR (primer pair F-R2) results on FLNA mini-genes expressed in Neuro2a cells, 
showing that the c.1429+182 G>A mutation caused > 40% of FLNA transcripts to include 
exonN.
M) Western blot of transfected Neuro2a cells detecting the WT mini-FLNA (green, arrow) 
and the truncated form (arrow head). Red, anti-Gapdh.
N) RT-PCR (primer pair F-R2) results of E14.5 mouse brains electroporated FLNA mini-
genes on E13.5, showing that the G>A mutation caused abnormal inclusion of exonN.
See also Figure S5.
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Figure 6. Alternative Exons Showing Higher Inclusion in Neurons Are Antagonistically 
Regulated by Ptbp1 and Rbfox1/2/3 Proteins
A) Unbiased motif analysis of alternative exons with higher inclusion in differentiating 
neurons reveals the enrichment of CU(C/U)UCUU in the 200 nt 5’ upstream region and 
GCAU(G/A) in the 200 nt downtream intronic region.
B) RNA-Seq results of sorted E14.5 mouse cortical cells showing that Ptbp1 is enriched in 
NPCs (VZ) and Rbfox1/2/3 transcripts are enriched in non-VZ cells. Data are represented as 
mean +/− SEM.
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C) A scatter plot showing that Ptbp1 knockdown in Neuro2a cells de-represses the inclusion 
of 24 neuronal exons predicted by motif search in A).
D) RT-PCR analysis showing that Ptbp1 knockdown in Neuro2a cells by three different 
shRNAs promotes inclusion of Flna exonN.
E) Western blot and quantified signals showing that Ptbp1 knockdown decreases Flna 
protein level. Data are represented as mean +/− SEM.
F) iCLIP-Seq (re-analysis of (Linares et al., 2015; Masuda et al., 2012)) and RNA-Seq 
results showing that Ptbp1 binds directly to Flna exonN and its flanking introns in NPCs and 
C2C12 cells. Red asterisk and dotted line indicate chrX:71,486,253, the homologous 
nucleotide of human ChrX: 153,594,210 C>T mutation. The arrow indicates direction of 
transcription.
G) Rbfox1/2/3 expression in Neuro2a cells promotes inclusion of 30 neuronal exons 
identified by motif analyses in A).
H) RT-PCR results showing that ectopic expression of Rbfox1/2/3 promotes inclusion of Nin 
exon 29.
I) Overexpression of Rbfox3 in U2OS cells decreases the protein level of centrosomal Nin 
(green). Data are represented as median +/− SD.
J) Genome browser views of RNA-Seq and HITS-CLIP reads (re-analysis of (Weyn-
Vanhentenryck et al., 2014)) showing that Rbfox1/2/3 proteins bind to conserved GCAUG 
motifs downstream of Nin exon 29 in mouse brains. Vertical red bars on top indicate 
GCATG sequences.
See also Figure S6 and Table S4.
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Figure 7. Ptbp1 and Rbfox Proteins Antagonistically Control Neural Progenitor Cell 
Differentiation
A) Immunostaining of E18.5 Ptbp1 conditional knockout (cKO, Nestin-Cre) cerebral cortex 
showing typical PVNH (white arrow) and thinner ventricular layer of Pax6+ cells (brackets).
B) Western blot of Ptbp1 cKO and control MEF cells showing that proteins level of Ptbp1, 
Flna and Flnb are decreased in Ptbp1 cKO, while Ptbp2 level is increased.
C) RT-PCR results showing that Ptbp1 cKO in MEF cells de-represses the inclusion of Flna 
exonN and a 98-nt Flnb exon.
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D) –E) Representative images and statistical analysis E) showing that Ptbp1 knockdown 
(green) at E13.5 results in reduced neural progenitors in the VZ at E15.5. The defect was 
partially rescued by co-expression of Ptbp1 coding sequence (CDS, red) or FLNA CDS. 
Numbers in parentheses indicate the number of embryos analyzed. Data are represented as 
mean +/− SD.
F) –G) Representative images and statistical analysis G) showing that introducing Rbfox3 
expression into E13.5 mouse brains resulted in reduced progenitor cells in the VZ and 
reduced neurons in the CP at E16.5. Ectopic expression of Rbfox3 on top of Ptbp1 
knockdown causes a more severe depletion of NPCs in the VZ. Data are represented as 
mean +/− SD.
H) A working model showing that Rbfox1/2/3 proteins are highly expressed in neurons and 
promote neuronal exon inclusion (red), while Ptbp1 is expressed in NPCs (blue, VZ) and 
represses neuronal exon inclusion. Sox2 binds to the promoter region of Ptbp1 (left). 
Dysregulation of Rbfox1/2/3 mediated AS may lead to brain disorders such as autism and 
intellectual disability. Mutations that de-represses neuronal exon inclusion in NPCs may 
result in PVNH (through FLNA).
See also Figure S7.
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